- Home
- MSGM vs NLSP Comparison
MSGM vs NLSP Comparison
Compare MSGM & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSGM
- NLSP
- Stock Information
- Founded
- MSGM 2018
- NLSP 2015
- Country
- MSGM United States
- NLSP Switzerland
- Employees
- MSGM N/A
- NLSP N/A
- Industry
- MSGM Computer Software: Prepackaged Software
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- MSGM Technology
- NLSP Health Care
- Exchange
- MSGM Nasdaq
- NLSP Nasdaq
- Market Cap
- MSGM 4.5M
- NLSP 5.2M
- IPO Year
- MSGM 2021
- NLSP 2021
- Fundamental
- Price
- MSGM $1.08
- NLSP $2.00
- Analyst Decision
- MSGM Hold
- NLSP
- Analyst Count
- MSGM 1
- NLSP 0
- Target Price
- MSGM $5.00
- NLSP N/A
- AVG Volume (30 Days)
- MSGM 28.7K
- NLSP 440.1K
- Earning Date
- MSGM 11-14-2024
- NLSP 12-31-2024
- Dividend Yield
- MSGM N/A
- NLSP N/A
- EPS Growth
- MSGM N/A
- NLSP N/A
- EPS
- MSGM 1.84
- NLSP N/A
- Revenue
- MSGM $8,460,953.00
- NLSP N/A
- Revenue This Year
- MSGM $23.00
- NLSP N/A
- Revenue Next Year
- MSGM $72.82
- NLSP N/A
- P/E Ratio
- MSGM $0.62
- NLSP N/A
- Revenue Growth
- MSGM N/A
- NLSP N/A
- 52 Week Low
- MSGM $1.01
- NLSP $1.75
- 52 Week High
- MSGM $4.16
- NLSP $24.32
- Technical
- Relative Strength Index (RSI)
- MSGM 40.37
- NLSP 22.65
- Support Level
- MSGM $1.12
- NLSP $1.75
- Resistance Level
- MSGM $1.40
- NLSP $2.13
- Average True Range (ATR)
- MSGM 0.10
- NLSP 0.29
- MACD
- MSGM -0.01
- NLSP -0.03
- Stochastic Oscillator
- MSGM 3.20
- NLSP 4.23
About MSGM Motorsport Games Inc.
Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.